| (+)-pilocarpine | increases expression | EXP | | 6480464 | Pilocarpine results in increased expression of MGMT mRNA | CTD | PMID:17971868 |
| (-)-epigallocatechin 3-gallate | increases expression | ISO | RGD:735904 | 6480464 | epigallocatechin gallate results in increased expression of MGMT mRNA | CTD | PMID:15703815 PMID:14633667 |
| (-)-epigallocatechin 3-gallate | increases expression | ISO | RGD:735904 | 6480464 | epigallocatechin gallate results in increased expression of MGMT mRNA | CTD | PMID:14633667 PMID:15703815 |
| (-)-epigallocatechin 3-gallate | decreases methylation | ISO | RGD:735904 | 6480464 | epigallocatechin gallate results in decreased methylation of MGMT promoter | CTD | PMID:14633667 |
| (S)-colchicine | multiple interactions | ISO | RGD:735904 | 6480464 | [MGMT protein co-treated with ABCB1 protein] results in decreased susceptibility to Colchicine | CTD | PMID:11792417 |
| 1,2-dibromoethane | multiple interactions | ISO | RGD:735904 | 6480464 | Ethylene Dibromide binds to and results in decreased activity of MGMT protein | CTD | PMID:12151404 |
| 1,2-dibromoethane | multiple interactions | ISO | RGD:735904 | 6480464 | MGMT protein results in increased activity of and results in increased susceptibility to Ethylene Dibromide | CTD | PMID:10894884 PMID:12151404 |
| 1,2-dibromoethane | increases response to substance | ISO | RGD:735904 | 6480464 | MGMT protein results in increased susceptibility to Ethylene Dibromide | CTD | PMID:17226938 |
| 1,2-dibromoethane | multiple interactions | ISO | RGD:735904 | 6480464 | MGMT protein affects the metabolism of and results in increased activity of Ethylene Dibromide | CTD | PMID:14645247 |
| 1,2-dibromoethane | multiple interactions | ISO | RGD:735904 | 6480464 | MGMT protein results in increased activity of and results in increased susceptibility to Ethylene Dibromide | CTD | PMID:12151404 PMID:10894884 |
| 1,2-dibromoethane | affects binding | ISO | RGD:735904 | 6480464 | Ethylene Dibromide binds to MGMT protein | CTD | PMID:17226938 |
| 1-chloro-2,4-dinitrobenzene | affects binding | ISO | RGD:735904 | 6480464 | Dinitrochlorobenzene binds to MGMT protein | CTD | PMID:12974631 |
| 2'-deoxyguanosine | decreases activity | ISO | RGD:735904 | 6480464 | Deoxyguanosine analog results in decreased activity of MGMT protein | CTD | PMID:17880193 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of MGMT mRNA | CTD | PMID:21215274 |
| 2,4-dinitrotoluene | affects expression | EXP | | 6480464 | 2,4-dinitrotoluene affects the expression of MGMT mRNA | CTD | PMID:21346803 |
| 2,6-dinitrotoluene | affects expression | EXP | | 6480464 | 2,6-dinitrotoluene affects the expression of MGMT mRNA | CTD | PMID:21346803 |
| 2-acetamidofluorene | increases expression | EXP | | 6480464 | 2-Acetylaminofluorene results in increased expression of MGMT mRNA | CTD | PMID:17070881 |
| 2-nitrofluorene | increases expression | EXP | | 6480464 | 2-nitrofluorene results in increased expression of MGMT mRNA | CTD | PMID:15890375 PMID:14600272 |
| 2-nitrofluorene | increases expression | EXP | | 6480464 | 2-nitrofluorene results in increased expression of MGMT mRNA | CTD | PMID:14600272 more ... |
| 2-nitrofluorene | increases expression | EXP | | 6480464 | 2-nitrofluorene results in increased expression of MGMT mRNA | CTD | PMID:14600272 more ... |
| 2-nitrofluorene | increases expression | EXP | | 6480464 | 2-nitrofluorene results in increased expression of MGMT mRNA | CTD | PMID:14600272 PMID:15890375 |
| 2-nitropropane | increases expression | EXP | | 6480464 | 2-nitropropane results in increased expression of MGMT mRNA | CTD | PMID:17070881 |
| 3H-1,2-dithiole-3-thione | increases expression | EXP | | 6480464 | 1,2-dithiol-3-thione results in increased expression of MGMT mRNA | CTD | PMID:19162173 |
| 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one | increases expression | EXP | | 6480464 | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of MGMT mRNA | CTD | PMID:15890375 PMID:14600272 |
| 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one | increases expression | EXP | | 6480464 | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of MGMT mRNA | CTD | PMID:14600272 more ... |
| 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one | increases expression | EXP | | 6480464 | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of MGMT mRNA | CTD | PMID:14600272 more ... |
| 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one | increases expression | EXP | | 6480464 | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of MGMT mRNA | CTD | PMID:14600272 PMID:15890375 |
| 4-hydroxyphenyl retinamide | multiple interactions | ISO | RGD:735904 | 6480464 | Fenretinide results in increased expression of and results in increased activity of MGMT protein | CTD | PMID:16950796 |
| 4-hydroxyphenyl retinamide | increases expression | ISO | RGD:735904 | 6480464 | Fenretinide results in increased expression of MGMT protein | CTD | PMID:15059897 |
| 4-hydroxyphenyl retinamide | increases expression | ISO | RGD:735904 | 6480464 | Fenretinide results in increased expression of MGMT mRNA | CTD | PMID:16950796 |
| 4-nitro-1,2-phenylenediamine | increases expression | EXP | | 6480464 | 1,2-diamino-4-nitrobenzene results in increased expression of MGMT mRNA | CTD | PMID:17070881 |
| 5-aza-2'-deoxycytidine | multiple interactions | ISO | RGD:735904 | 6480464 | [decitabine co-treated with trichostatin A] results in increased expression of MGMT mRNA; more ... | CTD | PMID:15657354 |
| 5-aza-2'-deoxycytidine | increases expression | ISO | RGD:735904 | 6480464 | decitabine results in increased expression of MGMT mRNA | CTD | PMID:15657354 more ... |
| 5-aza-2'-deoxycytidine | increases expression | ISO | RGD:735904 | 6480464 | decitabine results in increased expression of MGMT mRNA | CTD | PMID:19215824 more ... |
| 5-aza-2'-deoxycytidine | increases expression | ISO | RGD:735904 | 6480464 | decitabine results in increased expression of MGMT mRNA | CTD | PMID:19215824 more ... |
| 5-aza-2'-deoxycytidine | increases expression | ISO | RGD:735904 | 6480464 | decitabine results in increased expression of MGMT mRNA | CTD | PMID:15703815 more ... |
| 5-aza-2'-deoxycytidine | increases expression | ISO | RGD:735904 | 6480464 | decitabine results in increased expression of MGMT mRNA | CTD | PMID:15703815 more ... |
| 5-aza-2'-deoxycytidine | decreases expression | ISO | RGD:735904 | 6480464 | decitabine results in decreased expression of MGMT protein | CTD | PMID:18021753 |
| 5-aza-2'-deoxycytidine | decreases methylation | ISO | RGD:735904 | 6480464 | decitabine results in decreased methylation of MGMT promoter | CTD | PMID:15703815 |
| 5-azacytidine | increases expression | ISO | RGD:735904 | 6480464 | Azacitidine results in increased expression of MGMT mRNA | CTD | PMID:12807730 |
| 5-azacytidine | decreases methylation | ISO | RGD:735904 | 6480464 | Azacitidine results in decreased methylation of MGMT protein | CTD | PMID:7511991 |
| 5-fluorouracil | decreases expression | ISO | RGD:735904 | 6480464 | Fluorouracil results in decreased expression of MGMT mRNA; more ... | CTD | PMID:17487405 |
| 5-fluorouracil | multiple interactions | ISO | RGD:735904 | 6480464 | O(6)-benzylguanine inhibits the reaction [MGMT protein results in decreased susceptibility to Fluorouracil] | CTD | PMID:17487405 |
| 5-fluorouracil | decreases response to substance | ISO | RGD:735904 | 6480464 | MGMT protein results in decreased susceptibility to Fluorouracil | CTD | PMID:17487405 |
| 7,12-dimethyltetraphene | multiple interactions | ISO | RGD:735904 | 6480464 | MGMT protein results in decreased susceptibility to [Methylnitrosourea co-treated with 9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] | CTD | PMID:12663516 |
| acrolein | decreases response to substance | ISO | RGD:735904 | 6480464 | MGMT protein results in decreased susceptibility to Acrolein | CTD | PMID:17485251 |
| aflatoxin B1 | increases expression | EXP | | 6480464 | Aflatoxin B1 results in increased expression of MGMT mRNA | CTD | PMID:15890375 more ... |
| aflatoxin B1 | increases expression | EXP | | 6480464 | Aflatoxin B1 results in increased expression of MGMT mRNA | CTD | PMID:14600272 more ... |
| aflatoxin B1 | increases expression | EXP | | 6480464 | Aflatoxin B1 results in increased expression of MGMT mRNA | CTD | PMID:14600272 more ... |
| aflatoxin B1 | decreases expression | ISO | RGD:735904 | 6480464 | Aflatoxin B1 results in decreased expression of MGMT mRNA | CTD | PMID:22100608 |
| aflatoxin B1 | increases expression | EXP | | 6480464 | Aflatoxin B1 results in increased expression of MGMT mRNA | CTD | PMID:21813463 more ... |
| aflatoxin B1 | increases expression | EXP | | 6480464 | Aflatoxin B1 results in increased expression of MGMT mRNA | CTD | PMID:14600272 more ... |
| aflatoxin B1 | affects expression | ISO | RGD:735904 | 6480464 | Aflatoxin B1 affects the expression of MGMT protein | CTD | PMID:20106945 |
| aflatoxin B1 | increases expression | EXP | | 6480464 | Aflatoxin B1 results in increased expression of MGMT mRNA | CTD | PMID:15890375 PMID:14600272 |
| alpha-carotene | affects response to substance | ISO | RGD:735904 | 6480464 | MGMT gene SNP affects the susceptibility to alpha-carotene | CTD | PMID:16014702 |
| ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of MGMT mRNA | CTD | PMID:16483693 |
| anthracen-2-amine | increases expression | EXP | | 6480464 | 2-anthramine results in increased expression of MGMT mRNA | CTD | PMID:23038007 |
| arsenite(3-) | multiple interactions | ISO | RGD:10896 | 6480464 | TRP53 protein affects the reaction [arsenite results in decreased expression of MGMT mRNA] | CTD | PMID:18929588 |
| arsenite(3-) | decreases expression | ISO | RGD:10896 | 6480464 | arsenite results in decreased expression of MGMT mRNA | CTD | PMID:18929588 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:10896 | 6480464 | Benzo(a)pyrene promotes the reaction [AHR protein binds to MGMT promoter] | CTD | PMID:19654925 |
| benzo[a]pyrene | increases expression | ISO | RGD:10896 | 6480464 | Benzo(a)pyrene results in increased expression of MGMT mRNA | CTD | PMID:22228805 PMID:22610609 |
| benzo[a]pyrene | increases expression | ISO | RGD:10896 | 6480464 | Benzo(a)pyrene results in increased expression of MGMT mRNA | CTD | PMID:22228805 |
| benzo[a]pyrene | decreases expression | ISO | RGD:735904 | 6480464 | Benzo(a)pyrene results in decreased expression of MGMT mRNA | CTD | PMID:20064835 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:10896 | 6480464 | [Benzo(a)pyrene co-treated with XPA gene mutant form co-treated with TRP53 gene mutant form] results in decreased expression of MGMT mRNA | CTD | PMID:21715664 |
| beta-carotene | affects response to substance | ISO | RGD:735904 | 6480464 | MGMT gene SNP affects the susceptibility to beta Carotene | CTD | PMID:16014702 |
| bezafibrate | increases expression | ISO | RGD:10896 | 6480464 | Bezafibrate results in increased expression of MGMT mRNA | CTD | PMID:15447978 |
| cadmium dichloride | increases expression | ISO | RGD:735904 | 6480464 | Cadmium Chloride results in increased expression of MGMT mRNA | CTD | PMID:12160620 |
| camptothecin | decreases expression | ISO | RGD:735904 | 6480464 | Camptothecin results in decreased expression of MGMT mRNA | CTD | PMID:18492797 |
| carboplatin | decreases expression | EXP | | 6480464 | Carboplatin results in decreased expression of MGMT mRNA | CTD | PMID:18172885 |
| carmustine | affects response to substance | ISO | RGD:735904 | 6480464 | MGMT protein affects the susceptibility to Carmustine | CTD | PMID:18430789 more ... |
| carmustine | decreases response to substance | ISO | RGD:735904 | 6480464 | MGMT protein results in decreased susceptibility to Carmustine | CTD | PMID:12479369 more ... |
| carmustine | multiple interactions | ISO | RGD:735904 | 6480464 | MGMT protein mutant form results in decreased susceptibility to [O(6)-benzylguanine co-treated with Carmustine] | CTD | PMID:12036916 more ... |
| carmustine | multiple interactions | ISO | RGD:735904 | 6480464 | MGMT protein mutant form results in decreased susceptibility to [Carmustine co-treated with O(6)-benzylguanine] | CTD | PMID:11945064 more ... |
| carmustine | decreases response to substance | ISO | RGD:735904 | 6480464 | MGMT protein results in decreased susceptibility to Carmustine | CTD | PMID:16405512 more ... |
| carmustine | multiple interactions | ISO | RGD:735904 | 6480464 | MGMT protein mutant form results in decreased susceptibility to [O(6)-benzylguanine co-treated with Carmustine] | CTD | PMID:16432170 more ... |
| carmustine | decreases response to substance | ISO | RGD:735904 | 6480464 | MGMT protein results in decreased susceptibility to Carmustine | CTD | PMID:15814657 more ... |
| carmustine | multiple interactions | ISO | RGD:735904 | 6480464 | MGMT protein mutant form results in decreased susceptibility to [Carmustine co-treated with O(6)-benzylguanine] | CTD | PMID:12479369 more ... |
| carmustine | affects response to substance | ISO | RGD:735904 | 6480464 | MGMT protein affects the susceptibility to Carmustine | CTD | PMID:12394182 more ... |
| carmustine | multiple interactions | ISO | RGD:735904 | 6480464 | MGMT protein mutant form results in decreased susceptibility to [O(6)-benzylguanine co-treated with Carmustine] | CTD | PMID:12036916 more ... |
| carmustine | decreases response to substance | ISO | RGD:735904 | 6480464 | MGMT protein results in decreased susceptibility to Carmustine | CTD | PMID:15833865 more ... |
| carmustine | multiple interactions | ISO | RGD:735904 | 6480464 | MGMT protein mutant form results in decreased susceptibility to [Carmustine co-treated with O(6)-benzylguanine] | CTD | PMID:14617757 more ... |
| carmustine | multiple interactions | ISO | RGD:735904 | 6480464 | MGMT protein mutant form results in decreased susceptibility to [Carmustine co-treated with O(6)-benzylguanine] | CTD | PMID:12479369 more ... |
| carmustine | multiple interactions | ISO | RGD:735904 | 6480464 | MGMT protein mutant form results in decreased susceptibility to [O(6)-benzylguanine co-treated with Carmustine] | CTD | PMID:15319033 more ... |
| carmustine | multiple interactions | ISO | RGD:735904 | 6480464 | MGMT protein mutant form results in decreased susceptibility to [O(6)-benzylguanine co-treated with Carmustine] | CTD | PMID:20450874 more ... |
| carmustine | decreases response to substance | ISO | RGD:735904 | 6480464 | MGMT protein results in decreased susceptibility to Carmustine | CTD | PMID:20556481 more ... |
| carmustine | multiple interactions | ISO | RGD:735904 | 6480464 | MGMT protein mutant form results in decreased susceptibility to [Carmustine co-treated with O(6)-benzylguanine] | CTD | PMID:14617757 more ... |
| carmustine | affects response to substance | ISO | RGD:735904 | 6480464 | MGMT protein affects the susceptibility to Carmustine | CTD | PMID:12394182 more ... |
| carmustine | multiple interactions | ISO | RGD:735904 | 6480464 | MGMT protein mutant form results in decreased susceptibility to [Carmustine co-treated with O(6)-benzylguanine] | CTD | PMID:12479369 more ... |
| carmustine | decreases response to substance | ISO | RGD:735904 | 6480464 | MGMT protein mutant form results in decreased susceptibility to Carmustine | CTD | PMID:20450874 |
| carmustine | multiple interactions | ISO | RGD:735904 | 6480464 | [MGMT protein mutant form co-treated with FECH protein] results in decreased susceptibility to [O(6)-benzylguanine co-treated with Carmustine] | CTD | PMID:12950064 |
| carmustine | decreases response to substance | ISO | RGD:735904 | 6480464 | MGMT mRNA results in decreased susceptibility to Carmustine | CTD | PMID:16365179 |
| carmustine | affects response to substance | ISO | RGD:735904 | 6480464 | MGMT protein affects the susceptibility to Carmustine | CTD | PMID:16033832 more ... |
| carmustine | affects response to substance | ISO | RGD:735904 | 6480464 | MGMT promoter modified form affects the susceptibility to Carmustine | CTD | PMID:19637364 |
| carmustine | multiple interactions | ISO | RGD:735904 | 6480464 | [MGMT protein co-treated with ABCB1 protein] results in decreased susceptibility to Carmustine | CTD | PMID:11792417 |
| carmustine | affects response to substance | ISO | RGD:735904 | 6480464 | MGMT gene modified form affects the susceptibility to Carmustine | CTD | PMID:12684420 |
| carmustine | increases alkylation | ISO | RGD:735904 | 6480464 | Carmustine results in increased alkylation of MGMT protein | CTD | PMID:8823159 |
| carmustine | decreases expression | EXP | | 6480464 | Carmustine results in decreased expression of MGMT protein | CTD | PMID:15104113 |
| carmustine | multiple interactions | ISO | RGD:10896 | 6480464 | [O(6)-benzylguanine results in decreased activity of MGMT protein] which affects the susceptibility to Carmustine | CTD | PMID:19844954 |
| carmustine | multiple interactions | ISO | RGD:10896 | 6480464 | MGMT protein results in decreased susceptibility to [Carmustine co-treated with O(6)-benzylguanine] | CTD | PMID:19415780 |
| carmustine | decreases response to substance | ISO | RGD:10896 | 6480464 | MGMT protein results in decreased susceptibility to Carmustine | CTD | PMID:15284838 |
| carmustine | multiple interactions | ISO | RGD:10896 | 6480464 | MGMT protein mutant form results in decreased susceptibility to [Carmustine co-treated with O(6)-benzylguanine] | CTD | PMID:14707273 |
| carmustine | multiple interactions | ISO | RGD:735904 | 6480464 | [Tamoxifen results in increased degradation of MGMT protein] which results in increased susceptibility to Carmustine | CTD | PMID:17597106 |
| carmustine | affects response to substance | ISO | RGD:10896 | 6480464 | MGMT protein affects the susceptibility to Carmustine | CTD | PMID:19844954 |
| carmustine | decreases activity | ISO | RGD:10896 | 6480464 | Carmustine results in decreased activity of MGMT protein | CTD | PMID:16126841 |
| carmustine | multiple interactions | ISO | RGD:735904 | 6480464 | [O(6)-benzyl-N-acetylguanosine results in decreased activity of MGMT protein] which results in increased susceptibility to Carmustine | CTD | PMID:12394182 |
| carmustine | multiple interactions | ISO | RGD:735904 | 6480464 | [O(6)-benzylguanine results in decreased activity of MGMT protein] which results in increased susceptibility to Carmustine | CTD | PMID:14707273 PMID:14506174 |
| carmustine | multiple interactions | ISO | RGD:735904 | 6480464 | O(6)-benzylguanine inhibits the reaction [MGMT protein mutant form results in decreased susceptibility to Carmustine] | CTD | PMID:20450874 |
| carmustine | multiple interactions | ISO | RGD:735904 | 6480464 | [O(6)-benzylguanine co-treated with Carmustine] results in decreased activity of MGMT protein | CTD | PMID:16278409 |
| carmustine | multiple interactions | ISO | RGD:735904 | 6480464 | [O(6)-benzyl-2'-deoxyguanosine results in decreased activity of MGMT protein] which results in increased susceptibility to Carmustine | CTD | PMID:14506174 |
| carmustine | decreases response to substance | ISO | RGD:735904 | 6480464 | MGMT results in decreased susceptibility to Carmustine | CTD | PMID:9918549 |
| carmustine | decreases response to substance | ISO | RGD:735904 | 6480464 | MGMT protein results in decreased susceptibility to Carmustine analog | CTD | PMID:20654586 |
| carmustine | multiple interactions | ISO | RGD:735904 | 6480464 | MGMT protein results in decreased susceptibility to [O(6)-benzylguanine co-treated with Carmustine] | CTD | PMID:15319033 |
| carmustine | multiple interactions | ISO | RGD:735904 | 6480464 | MGMT protein results in decreased susceptibility to [Carmustine co-treated with O(6)-benzylguanine] | CTD | PMID:19415780 |
| carmustine | decreases response to substance | ISO | RGD:735904 | 6480464 | MGMT protein results in decreased susceptibility to Carmustine | CTD | PMID:14742745 more ... |
| carmustine | multiple interactions | ISO | RGD:735904 | 6480464 | MGMT protein mutant form results in decreased susceptibility to [O(6)-benzylguanine co-treated with Carmustine] | CTD | PMID:12036916 more ... |
| carmustine | multiple interactions | ISO | RGD:735904 | 6480464 | [O(6)-benzylguanine results in decreased activity of MGMT protein] which results in increased susceptibility to Carmustine | CTD | PMID:14506174 PMID:14707273 |
| carmustine | multiple interactions | ISO | RGD:735904 | 6480464 | MGMT protein mutant form results in decreased susceptibility to [O(6)-benzylguanine co-treated with Carmustine] | CTD | PMID:16432170 more ... |
| carmustine | decreases response to substance | ISO | RGD:735904 | 6480464 | MGMT protein results in decreased susceptibility to Carmustine | CTD | PMID:15833865 more ... |
| carmustine | multiple interactions | ISO | RGD:735904 | 6480464 | MGMT protein mutant form results in decreased susceptibility to [Carmustine co-treated with O(6)-benzylguanine] | CTD | PMID:11945064 more ... |
| chloroacetaldehyde | decreases response to substance | ISO | RGD:735904 | 6480464 | MGMT protein results in decreased susceptibility to chloroacetaldehyde | CTD | PMID:17485251 |
| chloroethene | decreases expression | EXP | | 6480464 | Vinyl Chloride results in decreased expression of MGMT protein | CTD | PMID:15256147 |
| chloroform | increases expression | EXP | | 6480464 | Chloroform results in increased expression of MGMT mRNA | CTD | PMID:21813463 |
| cisplatin | decreases activity | ISO | RGD:735904 | 6480464 | Cisplatin results in decreased activity of MGMT protein | CTD | PMID:15015788 more ... |
| cisplatin | decreases activity | ISO | RGD:735904 | 6480464 | Cisplatin results in decreased activity of MGMT protein | CTD | PMID:2766459 more ... |
| cisplatin | decreases activity | ISO | RGD:735904 | 6480464 | Cisplatin results in decreased activity of MGMT protein | CTD | PMID:2766459 more ... |
| cisplatin | decreases activity | ISO | RGD:735904 | 6480464 | Cisplatin results in decreased activity of MGMT protein | CTD | PMID:15015788 more ... |
| cisplatin | decreases expression | ISO | RGD:735904 | 6480464 | Cisplatin results in decreased expression of MGMT mRNA | CTD | PMID:16043385 PMID:15809756 |
| cisplatin | decreases activity | ISO | RGD:735904 | 6480464 | Cisplatin results in decreased activity of MGMT protein | CTD | PMID:7562019 more ... |
| cisplatin | decreases response to substance | ISO | RGD:735904 | 6480464 | MGMT protein results in decreased susceptibility to Cisplatin | CTD | PMID:16043385 |
| cisplatin | decreases expression | ISO | RGD:735904 | 6480464 | Cisplatin results in decreased expression of MGMT protein | CTD | PMID:16043385 |
| cisplatin | decreases expression | ISO | RGD:735904 | 6480464 | Cisplatin results in decreased expression of MGMT mRNA | CTD | PMID:15809756 PMID:16043385 |
| clofibric acid | decreases expression | EXP | | 6480464 | Clofibric Acid results in decreased expression of MGMT mRNA | CTD | PMID:17602206 |
| clofibric acid | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of MGMT mRNA | CTD | PMID:17602206 |
| cobalt dichloride | decreases expression | ISO | RGD:735904 | 6480464 | cobaltous chloride results in decreased expression of MGMT mRNA | CTD | PMID:19376846 |
| copper atom | increases expression | EXP | | 6480464 | Copper deficiency results in increased expression of MGMT mRNA | CTD | PMID:17418555 |
| copper(0) | increases expression | EXP | | 6480464 | Copper deficiency results in increased expression of MGMT mRNA | CTD | PMID:17418555 |
| curcumin | decreases expression | ISO | RGD:735904 | 6480464 | Curcumin results in decreased expression of MGMT mRNA | CTD | PMID:17596214 |
| curcumin | increases expression | ISO | RGD:735904 | 6480464 | Curcumin results in increased expression of MGMT mRNA | CTD | PMID:16950796 |
| curcumin | decreases activity | ISO | RGD:735904 | 6480464 | Curcumin results in decreased activity of MGMT protein | CTD | PMID:16950796 |
| curcumin | multiple interactions | ISO | RGD:735904 | 6480464 | Curcumin results in increased expression of and results in increased activity of MGMT protein | CTD | PMID:16950796 |
| cyclophosphamide | decreases expression | ISO | RGD:735904 | 6480464 | Cyclophosphamide results in decreased expression of MGMT mRNA | CTD | PMID:17403535 |
| cyclophosphamide | decreases response to substance | ISO | RGD:735904 | 6480464 | MGMT protein results in decreased susceptibility to Cyclophosphamide | CTD | PMID:15741301 |
| cyclosporin A | decreases expression | ISO | RGD:735904 | 6480464 | Cyclosporine results in decreased expression of MGMT mRNA | CTD | PMID:20106945 |
| cypermethrin | increases expression | ISO | RGD:10896 | 6480464 | cypermethrin results in increased expression of MGMT mRNA | CTD | PMID:21142847 |
| dacarbazine | decreases activity | ISO | RGD:735904 | 6480464 | Dacarbazine results in decreased activity of MGMT protein | CTD | PMID:12494480 |
| dacarbazine | decreases response to substance | ISO | RGD:735904 | 6480464 | MGMT protein results in decreased susceptibility to Dacarbazine | CTD | PMID:10751609 more ... |
| dacarbazine | decreases response to substance | ISO | RGD:735904 | 6480464 | MGMT protein results in decreased susceptibility to Dacarbazine | CTD | PMID:10751609 more ... |
| dacarbazine | decreases response to substance | ISO | RGD:735904 | 6480464 | MGMT protein results in decreased susceptibility to Dacarbazine | CTD | PMID:15870882 more ... |
| dacarbazine | increases response to substance | ISO | RGD:10896 | 6480464 | MGMT gene mutant form results in increased susceptibility to Dacarbazine | CTD | PMID:11023546 PMID:15010317 |
| dacarbazine | decreases response to substance | ISO | RGD:735904 | 6480464 | MGMT protein results in decreased susceptibility to Dacarbazine | CTD | PMID:15870882 more ... |
| dacarbazine | increases response to substance | ISO | RGD:10896 | 6480464 | MGMT gene mutant form results in increased susceptibility to Dacarbazine | CTD | PMID:15010317 PMID:11023546 |
| dacarbazine | affects response to substance | ISO | RGD:735904 | 6480464 | MGMT protein affects the susceptibility to Dacarbazine | CTD | PMID:14562026 |
| dacarbazine | decreases response to substance | ISO | RGD:735904 | 6480464 | MGMT protein results in decreased susceptibility to Dacarbazine | CTD | PMID:12170182 more ... |
| dacarbazine | decreases expression | ISO | RGD:735904 | 6480464 | Dacarbazine results in decreased expression of MGMT protein | CTD | PMID:12494480 |
| dexamethasone | multiple interactions | ISO | RGD:735904 | 6480464 | Dexamethasone promotes the reaction [MGMT protein results in decreased susceptibility to Nimustine]; more ... | CTD | PMID:15481722 |
| dexamethasone | multiple interactions | ISO | RGD:10896 | 6480464 | Mifepristone inhibits the reaction [Dexamethasone results in increased expression of MGMT mRNA] | CTD | PMID:20308330 |
| dexamethasone | increases expression | ISO | RGD:10896 | 6480464 | Dexamethasone results in increased expression of MGMT mRNA | CTD | PMID:20308330 |
| dexamethasone | increases activity | ISO | RGD:10896 | 6480464 | Dexamethasone results in increased activity of MGMT protein | CTD | PMID:20308330 |
| dexamethasone | increases expression | ISO | RGD:735904 | 6480464 | Dexamethasone results in increased expression of MGMT mRNA | CTD | PMID:15481722 |
| dichlorine | multiple interactions | EXP | | 6480464 | [Ozone co-treated with Chlorine] results in decreased expression of MGMT mRNA | CTD | PMID:18636392 |
| dichlorvos | increases expression | EXP | | 6480464 | Dichlorvos results in increased expression of MGMT mRNA | CTD | PMID:21813463 |
| diethyl maleate | decreases activity | ISO | RGD:735904 | 6480464 | diethyl maleate results in decreased activity of MGMT protein | CTD | PMID:16950796 |
| diethylstilbestrol | increases expression | EXP | | 6480464 | Diethylstilbestrol results in increased expression of MGMT mRNA | CTD | PMID:15890375 |
| dimethyl sulfate | increases alkylation | ISO | RGD:735904 | 6480464 | dimethyl sulfate results in increased alkylation of MGMT protein | CTD | PMID:8823159 |
| doxorubicin | decreases response to substance | ISO | RGD:735904 | 6480464 | MGMT promoter modified form results in decreased susceptibility to Doxorubicin | CTD | PMID:16356834 |
| doxorubicin | increases expression | ISO | RGD:10896 | 6480464 | Doxorubicin results in increased expression of MGMT mRNA | CTD | PMID:22712078 |
| fenofibrate | multiple interactions | EXP | | 6480464 | [Fenofibrate co-treated with Diethylnitrosamine] results in increased expression of MGMT mRNA | CTD | PMID:18253720 |
| fenofibrate | increases expression | EXP | | 6480464 | Fenofibrate results in increased expression of MGMT mRNA | CTD | PMID:17264098 |
| folic acid | multiple interactions | ISO | RGD:735904 | 6480464 | [Folic Acid co-treated with MTHFR gene SNP] affects the methylation of MGMT promoter | CTD | PMID:17301267 |
| fonofos | increases methylation | ISO | RGD:735904 | 6480464 | Fonofos results in increased methylation of MGMT promoter | CTD | PMID:22847954 |
| furan | increases expression | EXP | | 6480464 | furan results in increased expression of MGMT mRNA | CTD | PMID:22507866 |
| gallic acid | decreases expression | ISO | RGD:735904 | 6480464 | Gallic Acid results in decreased expression of MGMT mRNA | CTD | PMID:21887735 |
| geldanamycin | multiple interactions | ISO | RGD:735904 | 6480464 | geldanamycin results in increased expression of and results in increased activity of MGMT protein | CTD | PMID:16950796 |
| genistein | increases expression | ISO | RGD:735904 | 6480464 | Genistein results in increased expression of MGMT mRNA | CTD | PMID:15703815 |
| glutathione | multiple interactions | ISO | RGD:735904 | 6480464 | Glutathione affects the reaction [MGMT protein results in increased susceptibility to Mitomycin] | CTD | PMID:16039682 |
| guanine | decreases activity | ISO | RGD:735904 | 6480464 | Guanine analog results in decreased activity of MGMT protein | CTD | PMID:18783719 PMID:17880193 |
| guanine | decreases activity | ISO | RGD:735904 | 6480464 | Guanine analog results in decreased activity of MGMT protein | CTD | PMID:17880193 PMID:18783719 |
| hydralazine | decreases methylation | ISO | RGD:735904 | 6480464 | Hydralazine results in decreased methylation of MGMT promoter | CTD | PMID:15862127 |
| hydralazine | increases expression | ISO | RGD:735904 | 6480464 | Hydralazine results in increased expression of MGMT mRNA | CTD | PMID:15862127 |
| hydroxyurea | increases expression | ISO | RGD:10896 | 6480464 | Hydroxyurea results in increased expression of MGMT mRNA | CTD | PMID:12929121 |
| iodomethane | increases alkylation | ISO | RGD:735904 | 6480464 | methyl iodide results in increased alkylation of MGMT protein | CTD | PMID:8823159 |
| iodomethane | multiple interactions | ISO | RGD:735904 | 6480464 | [methyl iodide results in increased alkylation of MGMT protein] which affects the folding of MGMT protein modified form | CTD | PMID:8823159 |
| kojic acid | multiple interactions | EXP | | 6480464 | Ascorbic Acid inhibits the reaction [[kojic acid co-treated with Diethylnitrosamine] results in increased expression of MGMT mRNA] | CTD | PMID:18544905 |
| L-ascorbic acid | multiple interactions | EXP | | 6480464 | Ascorbic Acid inhibits the reaction [[kojic acid co-treated with Diethylnitrosamine] results in increased expression of MGMT mRNA] | CTD | PMID:18544905 |
| methapyrilene | increases expression | EXP | | 6480464 | Methapyrilene results in increased expression of MGMT mRNA | CTD | PMID:15890375 |
| methapyrilene | increases expression | EXP | | 6480464 | Methapyrilene results in increased expression of MGMT mRNA | CTD | PMID:15890375 PMID:21813463 |
| methapyrilene | increases expression | EXP | | 6480464 | Methapyrilene results in increased expression of MGMT mRNA | CTD | PMID:21813463 PMID:15890375 |
| methyl isocyanate | decreases activity | ISO | RGD:735904 | 6480464 | methyl isocyanate results in decreased activity of MGMT protein | CTD | PMID:14685775 |
| methyl methanesulfonate | increases alkylation | ISO | RGD:735904 | 6480464 | Methyl Methanesulfonate results in increased alkylation of MGMT protein | CTD | PMID:8823159 |
| methyl methanesulfonate | decreases response to substance | ISO | RGD:735904 | 6480464 | MGMT protein results in decreased susceptibility to Methyl Methanesulfonate | CTD | PMID:15833865 |
| miconazole | decreases expression | EXP | | 6480464 | Miconazole results in decreased expression of MGMT mRNA | CTD | PMID:22262564 |
| mifepristone | multiple interactions | ISO | RGD:10896 | 6480464 | Mifepristone inhibits the reaction [Dexamethasone results in increased expression of MGMT mRNA] | CTD | PMID:20308330 |
| mitomycin C | multiple interactions | ISO | RGD:735904 | 6480464 | Buthionine Sulfoximine inhibits the reaction [MGMT protein results in increased susceptibility to Mitomycin]; more ... | CTD | PMID:16039682 |
| mitomycin C | increases response to substance | ISO | RGD:735904 | 6480464 | MGMT protein results in increased susceptibility to Mitomycin | CTD | PMID:16039682 |
| N,N-dimethyl-4-nitrosoaniline | decreases expression | ISO | RGD:735904 | 6480464 | 4-nitrosodimethylaniline results in decreased expression of MGMT protein | CTD | PMID:15542103 |
| N,N-dimethyl-4-nitrosoaniline | decreases expression | EXP | | 6480464 | 4-nitrosodimethylaniline results in decreased expression of MGMT protein | CTD | PMID:15542103 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:735904 | 6480464 | Acetylcysteine results in increased expression of and results in increased activity of MGMT protein | CTD | PMID:16950796 |
| N-acetyl-L-cysteine | increases expression | ISO | RGD:735904 | 6480464 | Acetylcysteine results in increased expression of MGMT mRNA | CTD | PMID:16950796 |
| N-acetyl-L-cysteine | decreases activity | ISO | RGD:735904 | 6480464 | Acetylcysteine results in decreased activity of MGMT protein | CTD | PMID:16950796 |
| N-ethyl-N-nitrosourea | increases expression | EXP | | 6480464 | Ethylnitrosourea results in increased expression of MGMT mRNA | CTD | PMID:15954086 PMID:11599795 |
| N-ethyl-N-nitrosourea | increases expression | EXP | | 6480464 | Ethylnitrosourea results in increased expression of MGMT mRNA | CTD | PMID:11599795 PMID:15954086 |
| N-ethyl-N-nitrosourea | increases alkylation | ISO | RGD:735904 | 6480464 | Ethylnitrosourea results in increased alkylation of MGMT protein | CTD | PMID:8823159 |
| N-methyl-N'-nitro-N-nitrosoguanidine | decreases response to substance | ISO | RGD:735904 | 6480464 | MGMT protein results in decreased susceptibility to Methylnitronitrosoguanidine | CTD | PMID:16043385 PMID:1727384 |
| N-methyl-N'-nitro-N-nitrosoguanidine | decreases response to substance | ISO | RGD:735904 | 6480464 | MGMT protein results in decreased susceptibility to Methylnitronitrosoguanidine | CTD | PMID:1727384 PMID:16043385 |
| N-methyl-N'-nitro-N-nitrosoguanidine | decreases response to substance | ISO | RGD:10896 | 6480464 | MGMT protein results in decreased susceptibility to Methylnitronitrosoguanidine | CTD | PMID:15010311 |
| N-methyl-N-nitrosurea | increases alkylation | ISO | RGD:735904 | 6480464 | Methylnitrosourea results in increased alkylation of MGMT protein | CTD | PMID:8823159 |
| N-methyl-N-nitrosurea | decreases response to substance | ISO | RGD:735904 | 6480464 | MGMT protein results in decreased susceptibility to Methylnitrosourea | CTD | PMID:15870882 more ... |
| N-methyl-N-nitrosurea | decreases response to substance | ISO | RGD:10896 | 6480464 | MGMT protein results in decreased susceptibility to Methylnitrosourea | CTD | PMID:11276365 more ... |
| N-methyl-N-nitrosurea | decreases response to substance | ISO | RGD:10896 | 6480464 | MGMT protein results in decreased susceptibility to Methylnitrosourea | CTD | PMID:13679151 more ... |
| N-methyl-N-nitrosurea | decreases response to substance | ISO | RGD:10896 | 6480464 | MGMT protein results in decreased susceptibility to Methylnitrosourea | CTD | PMID:11536039 more ... |
| N-methyl-N-nitrosurea | decreases response to substance | ISO | RGD:735904 | 6480464 | MGMT protein results in decreased susceptibility to Methylnitrosourea | CTD | PMID:15870882 PMID:17507295 |
| N-methyl-N-nitrosurea | multiple interactions | ISO | RGD:10896 | 6480464 | MGMT protein inhibits the reaction [TRP53 gene mutant form results in increased susceptibility to Methylnitrosourea] | CTD | PMID:11536039 |
| N-methyl-N-nitrosurea | decreases response to substance | ISO | RGD:10896 | 6480464 | MGMT protein results in decreased susceptibility to Methylnitrosourea | CTD | PMID:11276365 more ... |
| N-methyl-N-nitrosurea | multiple interactions | ISO | RGD:10896 | 6480464 | MGMT protein affects the reaction [Methylnitrosourea results in increased activity of CASP3 protein]; more ... | CTD | PMID:13679151 |
| N-methyl-N-nitrosurea | decreases response to substance | ISO | RGD:735904 | 6480464 | MGMT protein results in decreased susceptibility to Methylnitrosourea | CTD | PMID:17507295 PMID:15870882 |
| N-methyl-N-nitrosurea | multiple interactions | ISO | RGD:735904 | 6480464 | MGMT protein results in decreased susceptibility to [Methylnitrosourea co-treated with 9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] | CTD | PMID:12663516 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of MGMT mRNA | CTD | PMID:17602206 |
| N-nitrosodiethylamine | increases expression | EXP | | 6480464 | Diethylnitrosamine results in increased expression of MGMT mRNA | CTD | PMID:11599795 more ... |
| N-nitrosodiethylamine | increases expression | EXP | | 6480464 | Diethylnitrosamine results in increased expression of MGMT mRNA | CTD | PMID:11599795 more ... |
| N-nitrosodiethylamine | increases expression | EXP | | 6480464 | Diethylnitrosamine results in increased expression of MGMT mRNA | CTD | PMID:17602206 more ... |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [kojic acid co-treated with Diethylnitrosamine] results in increased expression of MGMT mRNA; more ... | CTD | PMID:18544905 |
| N-nitrosodiethylamine | increases expression | EXP | | 6480464 | Diethylnitrosamine results in increased expression of MGMT mRNA | CTD | PMID:11599795 PMID:17602206 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [Fenofibrate co-treated with Diethylnitrosamine] results in increased expression of MGMT mRNA | CTD | PMID:18253720 |
| N-nitrosodimethylamine | increases expression | EXP | | 6480464 | Dimethylnitrosamine results in increased expression of MGMT mRNA | CTD | PMID:14600272 PMID:15890375 |
| N-nitrosodimethylamine | increases expression | EXP | | 6480464 | Dimethylnitrosamine results in increased expression of MGMT mRNA | CTD | PMID:15890375 PMID:14600272 |
| ochratoxin A | increases expression | EXP | | 6480464 | ochratoxin A results in increased expression of MGMT mRNA | CTD | PMID:23358140 |
| ozone | multiple interactions | EXP | | 6480464 | [Ozone co-treated with Chlorine] results in decreased expression of MGMT mRNA | CTD | PMID:18636392 |
| paclitaxel | increases expression | ISO | RGD:10896 | 6480464 | Paclitaxel results in increased expression of MGMT mRNA | CTD | PMID:12929121 |
| paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of MGMT mRNA | CTD | PMID:16751229 |
| paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of MGMT mRNA | CTD | PMID:12883083 |
| parathion | increases methylation | ISO | RGD:735904 | 6480464 | Parathion results in increased methylation of MGMT promoter | CTD | PMID:22847954 |
| phenobarbital | multiple interactions | ISO | RGD:10896 | 6480464 | NR1I3 protein affects the reaction [Phenobarbital results in decreased expression of MGMT mRNA] | CTD | PMID:19482888 |
| phenobarbital | decreases expression | ISO | RGD:10896 | 6480464 | Phenobarbital results in decreased expression of MGMT mRNA | CTD | PMID:19482888 |
| phenytoin | increases methylation | ISO | RGD:735904 | 6480464 | Phenytoin results in increased methylation of MGMT promoter | CTD | PMID:15949900 |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:735904 | 6480464 | MGMT protein results in decreased susceptibility to [Methylnitrosourea co-treated with 9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] | CTD | PMID:12663516 |
| piperonyl butoxide | increases expression | EXP | | 6480464 | Piperonyl Butoxide results in increased expression of MGMT mRNA | CTD | PMID:15890375 |
| pirinixic acid | increases expression | EXP | | 6480464 | pirinixic acid results in increased expression of MGMT mRNA | CTD | PMID:19162173 PMID:15890375 |
| pirinixic acid | increases expression | EXP | | 6480464 | pirinixic acid results in increased expression of MGMT mRNA | CTD | PMID:15890375 PMID:19162173 |
| potassium dichromate | increases expression | ISO | RGD:735904 | 6480464 | Potassium Dichromate results in increased expression of MGMT mRNA | CTD | PMID:18332044 |
| procarbazine | multiple interactions | ISO | RGD:735904 | 6480464 | MGMT affects the susceptibility to [Procarbazine co-treated with Vincristine co-treated with Nitrosourea Compounds] | CTD | PMID:16936459 |
| procarbazine | multiple interactions | ISO | RGD:735904 | 6480464 | MGMT protein affects the susceptibility to [Procarbazine co-treated with Lomustine co-treated with Vincristine] | CTD | PMID:16033832 |
| radon atom | increases methylation | ISO | RGD:735904 | 6480464 | Radon results in increased methylation of MGMT promoter | CTD | PMID:16902270 |
| radon(0) | increases methylation | ISO | RGD:735904 | 6480464 | Radon results in increased methylation of MGMT promoter | CTD | PMID:16902270 |
| resveratrol | multiple interactions | ISO | RGD:735904 | 6480464 | resveratrol results in increased expression of and results in increased activity of MGMT protein | CTD | PMID:16950796 |
| S-butyl-DL-homocysteine (S,R)-sulfoximine | multiple interactions | ISO | RGD:735904 | 6480464 | Buthionine Sulfoximine inhibits the reaction [MGMT protein results in increased susceptibility to Mitomycin] | CTD | PMID:16039682 |
| S-butyl-DL-homocysteine (S,R)-sulfoximine | decreases activity | ISO | RGD:735904 | 6480464 | Buthionine Sulfoximine results in decreased activity of MGMT protein | CTD | PMID:16950796 |
| silibinin | multiple interactions | ISO | RGD:735904 | 6480464 | silybin results in increased expression of and results in increased activity of MGMT protein | CTD | PMID:16950796 |
| streptozocin | decreases response to substance | ISO | RGD:735904 | 6480464 | MGMT protein results in decreased susceptibility to Streptozocin | CTD | PMID:16039682 |
| sulforaphane | multiple interactions | ISO | RGD:735904 | 6480464 | sulforafan results in increased expression of and results in increased activity of MGMT protein | CTD | PMID:16950796 |
| tamoxifen | decreases activity | ISO | RGD:735904 | 6480464 | Tamoxifen results in decreased activity of MGMT protein | CTD | PMID:17597106 |
| tamoxifen | increases degradation | ISO | RGD:735904 | 6480464 | Tamoxifen results in increased degradation of MGMT protein | CTD | PMID:17597106 |
| tamoxifen | multiple interactions | ISO | RGD:735904 | 6480464 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Tamoxifen results in increased degradation of MGMT protein]; more ... | CTD | PMID:17597106 |
| tamoxifen | decreases expression | ISO | RGD:735904 | 6480464 | Tamoxifen results in decreased expression of MGMT protein | CTD | PMID:17597106 |
| temozolomide | multiple interactions | ISO | RGD:735904 | 6480464 | [O(6)-benzyl-2'-deoxyguanosine results in decreased activity of MGMT protein] which results in increased susceptibility to temozolomide | CTD | PMID:14506174 |
| temozolomide | multiple interactions | ISO | RGD:735904 | 6480464 | [O(6)-benzylguanine results in decreased activity of MGMT protein] which results in increased susceptibility to temozolomide | CTD | PMID:12538819 more ... |
| temozolomide | multiple interactions | ISO | RGD:10896 | 6480464 | MGMT protein inhibits the reaction [temozolomide results in increased mutagenesis of HPRT1 gene] | CTD | PMID:17116724 |
| temozolomide | decreases activity | ISO | RGD:735904 | 6480464 | temozolomide results in decreased activity of MGMT protein | CTD | PMID:19056673 |
| temozolomide | multiple interactions | ISO | RGD:735904 | 6480464 | MGMT protein promotes the reaction [IL24 protein results in increased susceptibility to temozolomide] | CTD | PMID:19056673 |
| temozolomide | multiple interactions | ISO | RGD:735904 | 6480464 | MGMT protein results in decreased susceptibility to [O(6)-benzylguanine co-treated with temozolomide] | CTD | PMID:15319033 |
| temozolomide | decreases response to substance | ISO | RGD:735904 | 6480464 | MGMT protein results in decreased susceptibility to temozolomide | CTD | PMID:15758010 more ... |
| temozolomide | decreases response to substance | ISO | RGD:735904 | 6480464 | MGMT results in decreased susceptibility to temozolomide | CTD | PMID:9918549 |
| temozolomide | multiple interactions | ISO | RGD:735904 | 6480464 | MGMT protein affects the reaction [BCL2L1 protein affects the susceptibility to temozolomide] | CTD | PMID:16405512 |
| temozolomide | affects response to substance | ISO | RGD:735904 | 6480464 | MGMT promoter modified form affects the susceptibility to temozolomide | CTD | PMID:15297393 PMID:20167086 |
| temozolomide | affects response to substance | ISO | RGD:735904 | 6480464 | MGMT protein affects the susceptibility to temozolomide | CTD | PMID:15865885 PMID:18430789 |
| temozolomide | multiple interactions | ISO | RGD:735904 | 6480464 | MGMT protein mutant form results in decreased susceptibility to [O(6)-benzylguanine co-treated with temozolomide] | CTD | PMID:15319033 PMID:16432170 |
| temozolomide | multiple interactions | ISO | RGD:735904 | 6480464 | MGMT protein mutant form results in decreased susceptibility to [O(6)-(4-bromothenyl)guanine co-treated with temozolomide] | CTD | PMID:16075413 |
| temozolomide | decreases response to substance | ISO | RGD:735904 | 6480464 | MGMT mRNA results in decreased susceptibility to temozolomide | CTD | PMID:16365179 |
| temozolomide | decreases activity | ISO | RGD:10896 | 6480464 | temozolomide results in decreased activity of MGMT protein | CTD | PMID:10753191 |
| temozolomide | multiple interactions | ISO | RGD:735904 | 6480464 | O(6)-(4-bromothenyl)guanine inhibits the reaction [MGMT protein results in decreased susceptibility to temozolomide] | CTD | PMID:15486188 |
| terbufos | increases methylation | ISO | RGD:735904 | 6480464 | terbufos results in increased methylation of MGMT promoter | CTD | PMID:22847954 |
| tetrachloromethane | affects expression | ISO | RGD:10896 | 6480464 | Carbon Tetrachloride affects the expression of MGMT mRNA | CTD | PMID:17484886 |
| topotecan | decreases expression | ISO | RGD:735904 | 6480464 | Topotecan results in decreased expression of MGMT mRNA | CTD | PMID:18492797 |
| trans-resveratrol | multiple interactions | ISO | RGD:735904 | 6480464 | resveratrol results in increased expression of and results in increased activity of MGMT protein | CTD | PMID:16950796 |
| trichostatin A | multiple interactions | ISO | RGD:735904 | 6480464 | [decitabine co-treated with trichostatin A] results in increased expression of MGMT mRNA | CTD | PMID:15657354 |
| valproic acid | affects expression | ISO | RGD:10896 | 6480464 | Valproic Acid affects the expression of MGMT mRNA | CTD | PMID:17292431 |
| vincristine | increases response to substance | ISO | RGD:735904 | 6480464 | MGMT gene SNP results in increased susceptibility to Vincristine | CTD | PMID:20864405 |
| vincristine | multiple interactions | ISO | RGD:735904 | 6480464 | [MGMT protein co-treated with ABCB1 protein] results in decreased susceptibility to Vincristine | CTD | PMID:11792417 |
| vincristine | multiple interactions | ISO | RGD:735904 | 6480464 | MGMT protein affects the susceptibility to [Procarbazine co-treated with Lomustine co-treated with Vincristine] | CTD | PMID:16033832 |
| vincristine | multiple interactions | ISO | RGD:735904 | 6480464 | MGMT affects the susceptibility to [Procarbazine co-treated with Vincristine co-treated with Nitrosourea Compounds] | CTD | PMID:16936459 |
| zinc atom | multiple interactions | ISO | RGD:735904 | 6480464 | Zinc binds to and results in increased activity of and results in increased stability of MGMT protein | CTD | PMID:12549918 |
| zinc atom | multiple interactions | ISO | RGD:735904 | 6480464 | Zinc binds to and results in increased activity of MGMT protein | CTD | PMID:12974631 |
| zinc(0) | multiple interactions | ISO | RGD:735904 | 6480464 | Zinc binds to and results in increased activity of and results in increased stability of MGMT protein | CTD | PMID:12549918 |
| zinc(0) | multiple interactions | ISO | RGD:735904 | 6480464 | Zinc binds to and results in increased activity of MGMT protein | CTD | PMID:12974631 |